{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:16:41Z","timestamp":1790551001237,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T00:00:00Z","timestamp":1493769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1038\/leu.2017.133","type":"journal-article","created":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T06:58:51Z","timestamp":1493794731000},"page":"2615-2622","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells"],"prefix":"10.1038","volume":"31","author":[{"given":"M K","family":"Hasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G F","family":"Widhopf II","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Rassenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S P","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T J","family":"Kipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,3]]},"reference":[{"key":"BFleu2017133_CR1","doi-asserted-by":"crossref","first-page":"26181","DOI":"10.1016\/S0021-9258(18)35733-8","volume":"267","author":"P Masiakowski","year":"1992","unstructured":"Masiakowski P, Carroll RD . A novel family of cell surface receptors with tyrosine kinase-like domain. J Biol Chem 1992; 267: 26181\u201326190.","journal-title":"J Biol Chem"},{"key":"BFleu2017133_CR2","doi-asserted-by":"publisher","first-page":"7109","DOI":"10.1073\/pnas.90.15.7109","volume":"90","author":"C Wilson","year":"1993","unstructured":"Wilson C, Goberdhan DC, Steller H . Dror a potential neurotrophic receptor gene, encodes a Drosophila homolog of the vertebrate Ror family of Trk-related receptor tyrosine kinases. Proc Natl Acad Sci USA 1993; 90: 7109\u20137113.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2017133_CR3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/23722","volume":"400","author":"WC Forrester","year":"1999","unstructured":"Forrester WC, Dell M, Perens E, Garriga G . A C. elegans Ror receptor tyrosine kinase regulates cell motility and asymmetric cell division. Nature 1999; 400: 881\u2013885.","journal-title":"Nature"},{"key":"BFleu2017133_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00429-004-0381-6","volume":"207","author":"M Rodriguez-Niedenfuhr","year":"2004","unstructured":"Rodriguez-Niedenfuhr M, Prols F, Christ B . Expression and regulation of ROR-1 during early avian limb development. Anat Embryol (Berl) 2004; 207: 495\u2013502.","journal-title":"Anat Embryol (Berl)"},{"key":"BFleu2017133_CR5","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.leukres.2011.06.021","volume":"35","author":"HE Broome","year":"2011","unstructured":"Broome HE, Rassenti LZ, Wang HY, Meyer LM, Kipps TJ . ROR1 is expressed on hematogones (non-neoplastic human B-lymphocyte precursors) and a minority of precursor-B acute lymphoblastic leukemia. Leuk Res 2011; 35: 1390\u20131394.","journal-title":"Leuk Res"},{"key":"BFleu2017133_CR6","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1073\/pnas.0712148105","volume":"105","author":"T Fukuda","year":"2008","unstructured":"Fukuda T, Chen L, Endo T, Tang L, Lu D, Castro JE et al. Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a. Proc Natl Acad Sci USA 2008; 105: 3047\u20133052.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2017133_CR7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1158\/1078-0432.CCR-07-1823","volume":"14","author":"S Baskar","year":"2008","unstructured":"Baskar S, Kwong KY, Hofer T, Levy JM, Kennedy MG, Lee E et al. Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia. Clin Cancer Res 2008; 14: 396\u2013404.","journal-title":"Clin Cancer Res"},{"key":"BFleu2017133_CR8","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/ijc.23587","volume":"123","author":"AH Daneshmanesh","year":"2008","unstructured":"Daneshmanesh AH, Mikaelsson E, Jeddi-Tehrani M, Bayat AA, Ghods R, Ostadkarampour M et al. Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy. Int J Cancer 2008; 123: 1190\u20131195.","journal-title":"Int J Cancer"},{"key":"BFleu2017133_CR9","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1073\/pnas.1308374111","volume":"111","author":"GF Widhopf II","year":"2014","unstructured":"Widhopf GF II, Cui B, Ghia EM, Chen L, Messer K, Shen Z et al. ROR1 can interact with TCL1 and enhance leukemogenesis in Emu-TCL1 transgenic mice. Proc Natl Acad Sci USA 2014; 111: 793\u2013798.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2017133_CR10","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1182\/blood-2016-04-712562","volume":"128","author":"B Cui","year":"2016","unstructured":"Cui B, Ghia EM, Chen L, Rassenti LZ, DeBoever C, Widhopf GF II et al. High-level ROR1 associates with accelerated disease-progression in chronic lymphocytic leukemia. Blood 2016; 128: 2931\u20132940.","journal-title":"Blood"},{"key":"BFleu2017133_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1126\/science.1151250","volume":"320","author":"ES Witze","year":"2008","unstructured":"Witze ES, Litman ES, Argast GM, Moon RT, Ahn NG . Wnt5a control of cell polarity and directional movement by polarized redistribution of adhesion receptors. Science 2008; 320: 365\u2013369.","journal-title":"Science"},{"key":"BFleu2017133_CR12","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1172\/JCI83535","volume":"126","author":"J Yu","year":"2016","unstructured":"Yu J, Chen L, Cui B, Widhopf GF, Shen Z, Wu R et al. Wnt5a induces ROR1\/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation. J Clin Invest 2016; 126: 585\u2013598.","journal-title":"J Clin Invest"},{"issue":"Pt 2","key":"BFleu2017133_CR13","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1042\/bj20021791","volume":"371","author":"T Uruno","year":"2003","unstructured":"Uruno T, Zhang P, Liu J, Hao JJ, Zhan X . Haematopoietic lineage cell-specific protein 1 (HS1) promotes actin-related protein (Arp) 2\/3 complex-mediated actin polymerization. Biochem J 2003; 371 (Pt 2): 485\u2013493.","journal-title":"Biochem J"},{"key":"BFleu2017133_CR14","doi-asserted-by":"publisher","first-page":"37988","DOI":"10.1074\/jbc.M504552200","volume":"280","author":"JJ Hao","year":"2005","unstructured":"Hao JJ, Zhu J, Zhou K, Smith N, Zhan X . The coiled-coil domain is required for HS1 to bind to F-actin and activate Arp2\/3 complex. J Biol Chem 2005; 280: 37988\u201337994.","journal-title":"J Biol Chem"},{"key":"BFleu2017133_CR15","doi-asserted-by":"publisher","first-page":"e0118153","DOI":"10.1371\/journal.pone.0118153","volume":"10","author":"S Mukherjee","year":"2015","unstructured":"Mukherjee S, Kim J, Mooren OL, Shahan ST, Cohan M, Cooper JA . Role of cortactin homolog HS1 in transendothelial migration of natural killer cells. PLoS One 2015; 10: e0118153.","journal-title":"PLoS One"},{"key":"BFleu2017133_CR16","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/eji.201444473","volume":"45","author":"M Lettau","year":"2015","unstructured":"Lettau M, Kabelitz D, Janssen O . SDF1alpha-induced interaction of the adapter proteins Nck and HS1 facilitates actin polymerization and migration in T cells. Eur J Immunol 2015; 45: 551\u2013561.","journal-title":"Eur J Immunol"},{"key":"BFleu2017133_CR17","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.4049\/jimmunol.1600915","volume":"197","author":"E Ten Hacken","year":"2016","unstructured":"Ten Hacken E, Sivina M, Kim E, O'Brien S, Wierda WG, Ferrajoli A et al. Functional differences between IgM and IgD signaling in chronic lymphocytic leukemia. J Immunol 2016; 197: 2522\u20132531.","journal-title":"J Immunol"},{"key":"BFleu2017133_CR18","first-page":"9367","volume":"17","author":"D Kitamura","year":"1989","unstructured":"Kitamura D, Kaneko H, Miyagoe Y, Ariyasu T, Watanabe T . Isolation and characterization of a novel human gene expressed specifically in the cells of hematopoietic lineage. Nucleic Acids Res 1989; 17: 9367\u20139379.","journal-title":"Nucleic Acids Res"},{"key":"BFleu2017133_CR19","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1073\/pnas.92.8.3110","volume":"92","author":"K Alexandropoulos","year":"1995","unstructured":"Alexandropoulos K, Cheng G, Baltimore D . Proline-rich sequences that bind to Src homology 3 domains with individual specificities. Proc Natl Acad Sci USA 1995; 92: 3110\u20133114.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2017133_CR20","doi-asserted-by":"publisher","first-page":"5627","DOI":"10.1128\/MCB.15.10.5627","volume":"15","author":"Z Weng","year":"1995","unstructured":"Weng Z, Rickles RJ, Feng S, Richard S, Shaw AS, Schreiber SL et al. Structure-function analysis of SH3 domains: SH3 binding specificity altered by single amino acid substitutions. Mol Cell Biol 1995; 15: 5627\u20135634.","journal-title":"Mol Cell Biol"},{"key":"BFleu2017133_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.13172\/2052-9295-1-1-432","volume":"1","author":"N Martinez-Quiles","year":"2013","unstructured":"Martinez-Quiles N . Emerging roles of hematopoietic lineage cell-specific protein 1 in the immune system. OA Immunol 2013; 1: 1\u20137.","journal-title":"OA Immunol"},{"key":"BFleu2017133_CR22","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.leukres.2012.01.017","volume":"36","author":"A Butrym","year":"2012","unstructured":"Butrym A, Majewski M, Dzietczenia J, Kuliczkowski K, Mazur G . High expression of hematopoietic cell specific Lyn substrate-1 (HS1) predicts poor survival of B-cell chronic lymphocytic leukemia patients. Leuk Res 2012; 36: 876\u2013880.","journal-title":"Leuk Res"},{"key":"BFleu2017133_CR23","doi-asserted-by":"publisher","first-page":"e39902","DOI":"10.1371\/journal.pone.0039902","volume":"7","author":"F Frezzato","year":"2012","unstructured":"Frezzato F, Gattazzo C, Martini V, Trimarco V, Teramo A, Carraro S et al. HS1, a Lyn kinase substrate, is abnormally expressed in B-chronic lymphocytic leukemia and correlates with response to fludarabine-based regimen. PLoS One 2012; 7: e39902.","journal-title":"PLoS One"},{"key":"BFleu2017133_CR24","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1038\/sj.leu.2404744","volume":"21","author":"M Muzio","year":"2007","unstructured":"Muzio M, Scielzo C, Frenquelli M, Bachi A, De Palma M, Alessio M et al. HS1 complexes with cytoskeleton adapters in normal and malignant chronic lymphocytic leukemia B cells. Leukemia 2007; 21: 2067\u20132070.","journal-title":"Leukemia"},{"key":"BFleu2017133_CR25","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1182\/blood-2012-09-457119","volume":"121","author":"E ten Hacken","year":"2013","unstructured":"ten Hacken E, Scielzo C, Bertilaccio MT, Scarfo L, Apollonio B, Barbaglio F et al. Targeting the LYN\/HS1 signaling axis in chronic lymphocytic leukemia. Blood 2013; 121: 2264\u20132273.","journal-title":"Blood"},{"key":"BFleu2017133_CR26","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1172\/JCI24276","volume":"115","author":"C Scielzo","year":"2005","unstructured":"Scielzo C, Ghia P, Conti A, Bachi A, Guida G, Geuna M et al. HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses. J Clin Invest 2005; 115: 1644\u20131650.","journal-title":"J Clin Invest"},{"key":"BFleu2017133_CR27","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1182\/blood-2009-12-258814","volume":"116","author":"C Scielzo","year":"2010","unstructured":"Scielzo C, Bertilaccio MT, Simonetti G, Dagklis A, ten Hacken E, Fazi C et al. HS1 has a central role in the trafficking and homing of leukemic B cells. Blood 2010; 116: 3537\u20133546.","journal-title":"Blood"},{"key":"BFleu2017133_CR28","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood.V94.11.3658","volume":"94","author":"JA Burger","year":"1999","unstructured":"Burger JA, Burger M, Kipps TJ . Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood 1999; 94: 3658\u20133667.","journal-title":"Blood"},{"key":"BFleu2017133_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nchembio.481","volume":"7","author":"JA Di Paolo","year":"2011","unstructured":"Di Paolo JA, Huang T, Balazs M, Barbosa J, Barck KH, Bravo BJ et al. Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis. Nat Chem Biol 2011; 7: 41\u201350.","journal-title":"Nat Chem Biol"},{"key":"BFleu2017133_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0145-2126(98)00154-4","volume":"23","author":"A Stacchini","year":"1999","unstructured":"Stacchini A, Aragno M, Vallario A, Alfarano A, Circosta P, Gottardi D et al. MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. Leuk Res 1999; 23: 127\u2013136.","journal-title":"Leuk Res"},{"key":"BFleu2017133_CR31","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1073\/pnas.90.8.3631","volume":"90","author":"Y Yamanashi","year":"1993","unstructured":"Yamanashi Y, Okada M, Semba T, Yamori T, Umemori H, Tsunasawa S et al. Identification of HS1 protein as a major substrate of protein-tyrosine kinase(s) upon B-cell antigen receptor-mediated signaling. Proc Natl Acad Sci USA 1993; 90: 3631\u20133635.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2017133_CR32","doi-asserted-by":"publisher","first-page":"18485","DOI":"10.1074\/jbc.M100100200","volume":"276","author":"E Roszmusz","year":"2001","unstructured":"Roszmusz E, Patthy A, Trexler M, Patthy L . Localization of disulfide bonds in the frizzled module of Ror1 receptor tyrosine kinase. J Biol Chem 2001; 276: 18485\u201318490.","journal-title":"J Biol Chem"},{"key":"BFleu2017133_CR33","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1534\/genetics.104.031781","volume":"168","author":"WC Forrester","year":"2004","unstructured":"Forrester WC, Kim C, Garriga G . The Caenorhabditis elegans Ror RTK CAM-1 inhibits EGL-20\/Wnt signaling in cell migration. Genetics 2004; 168: 1951\u20131962.","journal-title":"Genetics"},{"key":"BFleu2017133_CR34","doi-asserted-by":"publisher","first-page":"R407","DOI":"10.1016\/S0960-9822(98)70263-5","volume":"8","author":"P Masiakowski","year":"1998","unstructured":"Masiakowski P, Yancopoulos GD . The Wnt receptor CRD domain is also found in MuSK and related orphan receptor tyrosine kinases. Curr Biol 1998; 8: R407.","journal-title":"Curr Biol"},{"key":"BFleu2017133_CR35","doi-asserted-by":"publisher","first-page":"R405","DOI":"10.1016\/S0960-9822(98)70262-3","volume":"8","author":"YK Xu","year":"1998","unstructured":"Xu YK, Nusse R . The Frizzled CRD domain is conserved in diverse proteins including several receptor tyrosine kinases. Curr Biol 1998; 8: R405\u2013R406.","journal-title":"Curr Biol"},{"key":"BFleu2017133_CR36","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/gtc.12342","volume":"21","author":"X Qi","year":"2016","unstructured":"Qi X, Okinaka Y, Nishita M, Minami Y . Essential role of Wnt5a-Ror1\/Ror2 signaling in metanephric mesenchyme and ureteric bud formation. Genes Cells 2016; 21: 325\u2013334.","journal-title":"Genes Cells"},{"key":"BFleu2017133_CR37","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/leu.2016.368","volume":"31","author":"J Yu","year":"2017","unstructured":"Yu J, Chen L, Cui B, Wu C, Choi MY, Chen Y et al. Cirmtuzumab inhibits Wnt5a-induced Rac1-activation in chronic lymphocytic leukemia treated with ibrutinib. Leukemia 2017; 31: 1333\u20131339.","journal-title":"Leukemia"},{"key":"BFleu2017133_CR38","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.immuni.2006.03.022","volume":"24","author":"TS Gomez","year":"2006","unstructured":"Gomez TS, McCarney SD, Carrizosa E, Labno CM, Comiskey EO, Nolz JC et al. HS1 functions as an essential actin-regulatory adaptor protein at the immune synapse. Immunity 2006; 24: 741\u2013752.","journal-title":"Immunity"},{"key":"BFleu2017133_CR39","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1091\/mbc.e04-12-1076","volume":"16","author":"K Kurokawa","year":"2005","unstructured":"Kurokawa K, Matsuda M . Localized RhoA activation as a requirement for the induction of membrane ruffling. Mol Biol Cell 2005; 16: 4294\u20134303.","journal-title":"Mol Biol Cell"},{"key":"BFleu2017133_CR40","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.4049\/jimmunol.1003102","volume":"186","author":"DA Dehring","year":"2011","unstructured":"Dehring DA, Clarke F, Ricart BG, Huang Y, Gomez TS, Williamson EK et al. Hematopoietic lineage cell-specific protein 1 functions in concert with the Wiskott-Aldrich syndrome protein to promote podosome array organization and chemotaxis in dendritic cells. J Immunol 2011; 186: 4805\u20134818.","journal-title":"J Immunol"},{"key":"BFleu2017133_CR41","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1093\/intimm\/11.12.1957","volume":"11","author":"Y Takemoto","year":"1999","unstructured":"Takemoto Y, Furuta M, Sato M, Kubo M, Hashimoto Y . Isolation and characterization of a novel HS1 SH3 domain binding protein, HS1BP3. Int Immunol 1999; 11: 1957\u20131964.","journal-title":"Int Immunol"},{"key":"BFleu2017133_CR42","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/nm.2958","volume":"18","author":"J Skokowa","year":"2012","unstructured":"Skokowa J, Klimiankou M, Klimenkova O, Lan D, Gupta K, Hussein K et al. Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF-triggered granulopoiesis. Nat Med 2012; 18: 1550\u20131559.","journal-title":"Nat Med"},{"key":"BFleu2017133_CR43","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.4049\/jimmunol.158.6.2736","volume":"158","author":"Y Suzuki","year":"1997","unstructured":"Suzuki Y, Demoliere C, Kitamura D, Takeshita H, Deuschle U, Watanabe T . HAX-1 a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of Src family tyrosine kinases. J Immunol 1997; 158: 2736\u20132744.","journal-title":"J Immunol"},{"key":"BFleu2017133_CR44","doi-asserted-by":"publisher","first-page":"7557","DOI":"10.1074\/jbc.274.11.7557","volume":"274","author":"AM Brunati","year":"1999","unstructured":"Brunati AM, Donella-Deana A, James P, Quadroni M, Contri A, Marin O et al. Molecular features underlying the sequential phosphorylation of HS1 protein and its association with c-Fgr protein-tyrosine kinase. J Biol Chem 1999; 274: 7557\u20137564.","journal-title":"J Biol Chem"},{"key":"BFleu2017133_CR45","doi-asserted-by":"publisher","first-page":"25466","DOI":"10.1074\/jbc.M112.364562","volume":"287","author":"PJ Cavnar","year":"2012","unstructured":"Cavnar PJ, Mogen K, Berthier E, Beebe DJ, Huttenlocher A . The actin regulatory protein HS1 interacts with Arp2\/3 and mediates efficient neutrophil chemotaxis. J Biol Chem 2012; 287: 25466\u201325477.","journal-title":"J Biol Chem"},{"issue":"Suppl","key":"BFleu2017133_CR46","doi-asserted-by":"publisher","first-page":"S167","DOI":"10.1016\/j.clml.2015.02.010","volume":"15","author":"MY Choi","year":"2015","unstructured":"Choi MY, Widhopf GF, Wu CC, Cui B, Lao F, Sadarangani A et al. Pre-clinical specificity and safety of UC-961, a first-in-class monoclonal antibody targeting ROR1. Clin Lymphoma Myeloma Leuk 2015; 15 (Suppl): S167\u2013S169.","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/leu2017133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu2017133","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/leu.2017.133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/leu2017133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T11:26:37Z","timestamp":1692789997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2017133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,3]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["BFleu2017133"],"URL":"https:\/\/doi.org\/10.1038\/leu.2017.133","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,3]]},"assertion":[{"value":"21 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Cirmtuzumab was developed in the Kipps laboratory and licensed by Oncternal Therapeutics, Inc. from the University of California, San Diego.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}